XML 30 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income (loss) $ 14,516 $ (20,834) $ (25,526)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operations:      
Impairments and other non-cash charges 6,356 37,322 0
Depreciation and amortization 31,372 38,610 42,225
Stock-based compensation expense 6,638 6,861 7,926
Provision for deferred income taxes (482) (3,384) (1,209)
Credit loss expense 1,209 1,039 664
Gain on divestitures 0 (3,596) 0
Gain on sale of assets (2,904) (2,809) (7,182)
Gain on insurance recovery 0 0 (849)
Loss on extinguishment of debt 0 0 1,000
Amortization of original issue discount and debt issuance costs 541 871 3,707
Change in assets and liabilities:      
(Increase) decrease in receivables 64,812 (42,452) (61,283)
(Increase) decrease in inventories 2,256 (46,909) (10,336)
(Increase) decrease in other assets 307 (855) (726)
Increase (decrease) in accounts payable (25,065) 10,781 36,341
Increase in accrued liabilities and other 445 334 12,235
Net cash provided by (used in) operating activities 100,001 (25,021) (3,013)
Cash flows from investing activities:      
Capital expenditures (29,232) (28,273) (21,793)
Proceeds from divestitures 19,833 71,286 0
Business acquisitions, net of cash acquired 0 0 (13,434)
Proceeds from sale of property, plant and equipment 3,709 3,217 15,999
Proceeds from insurance property claim 0 0 1,753
Net cash provided by (used in) investing activities (5,690) 46,230 (17,475)
Cash flows from financing activities:      
Borrowings on lines of credit 241,873 287,276 286,154
Payments on lines of credit (277,591) (290,886) (208,575)
Purchases of Convertible Notes 0 0 (28,137)
Payment on Convertible Notes 0 0 (38,567)
Proceeds from term loan 0 3,754 8,258
Proceeds from financing obligation 0 0 8,004
Debt issuance costs 0 (1,499) (295)
Purchases of treasury stock (34,265) (20,248) (1,448)
Proceeds from employee stock plans 606 0 0
Other financing activities (11,670) (3,327) (3,986)
Net cash provided by (used in) financing activities (81,047) (24,930) 21,408
Effect of exchange rate changes on cash 576 (707) (1,779)
Net increase (decrease) in cash, cash equivalents, and restricted cash 13,840 (4,428) (859)
Cash, cash equivalents, and restricted cash at beginning of year 25,061 29,489 30,348
Cash, cash equivalents, and restricted cash at end of year $ 38,901 $ 25,061 $ 29,489